Resveratrol Counteracts Insulin Resistance—Potential Role of the Circulation
AbstractPre-clinical data and human trials indicate that resveratrol supplementation may help to counteract diabetes. Several mechanisms of action have been proposed to explain its metabolic benefits, including activation of sirtuins and estrogen receptors (ER) to promote glucose transporter type-4 (GLUT4) translocation and increase glucose uptake. Resveratrol can also enhance vasodilator function, yet the possibility that this action might help to alleviate insulin resistance in type-2 diabetes mellitus has received little attention. In this brief review we propose that, by restoring impaired endothelium-dependent vasodilatation in insulin resistant individuals resveratrol increases blood perfusion of skeletal muscle, thereby facilitating glucose delivery and utilization with resultant improvement of insulin sensitivity. Thus, circulatory improvements by vasoactive nutrients such as resveratrol may play a role in preventing or alleviating insulin resistance. View Full-Text
Share & Cite This Article
Wong, R.H.X.; Howe, P.R.C. Resveratrol Counteracts Insulin Resistance—Potential Role of the Circulation. Nutrients 2018, 10, 1160.
Wong RHX, Howe PRC. Resveratrol Counteracts Insulin Resistance—Potential Role of the Circulation. Nutrients. 2018; 10(9):1160.Chicago/Turabian Style
Wong, Rachel H.X.; Howe, Peter R.C. 2018. "Resveratrol Counteracts Insulin Resistance—Potential Role of the Circulation." Nutrients 10, no. 9: 1160.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.